1 results match your criteria: "Hospital del Mar-IMIM. Barcelona. jhorcajada@psmar.cat.[Affiliation]"

Ceftolozane-tazobactam: When, how and why using it?

Rev Esp Quimioter

September 2021

Juan P. Horcajada, Department of Infectious Diseases, Hospital del Mar-IMIM. Barcelona.

Ceftolozane-tazobactam is currently the most active antipseudomonal agent, including multidrug-resistant extensively drug-resistant strains. Tazobactam provides additional activity against many extended-spectrum beta-lactamases Enterobacterales. Ceftolozane-tazobactam is formally approved for complicated urinary tract infection, complicated intra-abdominal infection, and hospital-acquired and ventilator-associated bacterial pneumonia.

View Article and Find Full Text PDF